Brivaracetam, serum or plasma

Alphabetical Test listing

Brivaracetam, serum or plasma-16016

Test name:

Test number:

16016

Excellian order number:

LAB16016

Abbreviation:

BRIV

Alternate names:

Briviact

Useful for:

Therapeutic drug monitoring (TDM)

Patient preparation information:

Draw blood immediately before next scheduled dose.

Specimen type:

Serum

Collection container:

Red serum vial/tube, 5 mL

Volume:

2.0 mL

Minimum volume:

0.5 mL

Collection instructions:

Immediately following collection, mix sample thoroughly by gentle inverting 8 - 10 times, to prevent clotting

Processing instructions:

Allow sample to clot for a minimum of 30 minutes
Spin within two (2) hours of sample collection
Transfer vial/tube with cap - 12mL (LabCorp), labelled as the appropriate plasma

Transport container:

Transfer vial/tube with cap - 12mL (LabCorp)

Alternate specimen type:

Heparin plasma

Alternate collection container:

Dk green heparin (Li or Na), no gel

Transport and stability:

Refrigerated (preferred) - 6 days

Ambient - 6 days

Frozen - 16 days

Reason for rejection:

Whole blood
Gel barrier tubes

Performing lab:

LabCorp Burlington (702800): R-LC

TAT:

3 - 5 days

Method:

Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS)

Reference ranges:

See report

CPT codes:

80299

Subject to medical necessity (Y/N):

Yes

LCD/NCD:

Medical necessity

Date created:

12/14/2018

Revised date:

10/28/2025

Review date:

03/25/2025